[Summary] A comprehensive large-scale pharmaceutical enterprise integrating new
Lepu (Beijing) Medical Device Co., Ltd. was established in 1999, jointly funded by the 725th Research Institute of China Shipbuilding Industry Corporation and American WP Company. Currently, the company has developed into a leading medical product industry group, with products covering cardiovascular interventional diagnosis and treatment devices, equipment, and drugs. It has initially established a platform for the entire cardiovascular industry chain, integrating devices, pharmaceuticals, mobile healthcare, and services.
As one of the strategic sectors of Lepu Medical, Lepu Pharmaceuticals continuously improves its product portfolio, extending from antithrombotic, lipid-lowering, and heart failure treatment to antihypertensive fields. Its core products, such as Shuaital (Clopidogrel Bisulfate Tablets), Youliping (Atorvastatin Calcium Tablets), Haihetianxin (Levosimendan Injection), and Yuanstatin (Losartan Potassium and Hydrochlorothiazide Tablets), have driven explosive growth in the pharmaceutical segment's performance.
: *
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
